Geometric mean titre ratios (Day22:Day1) in all subjects in the Phase II/III trial

<p><b>Copyright information:</b></p><p>Taken from "Safety and immunogenicity of an MF59™-adjuvanted subunit influenza vaccine in elderly Chinese subjects"</p><p>http://www.immunityageing.com/content/5/1/2</p><p>Immunity & ageing : I & A 2008;5():2-2.</p><p>Published online 20 Feb 2008</p><p>PMCID:PMC2291031.</p><p></p

Pre-vaccination (Day 1) and post-vaccination (Day 22) geometric mean titre against a) A/H1N1, b) A/H3N2 and c) B viral strains in subjects without pre-vaccination immunoprotection

<p><b>Copyright information:</b></p><p>Taken from "Safety and immunogenicity of an MF59™-adjuvanted subunit influenza vaccine in elderly Chinese subjects"</p><p>http://www.immunityageing.com/content/5/1/2</p><p>Immunity & ageing : I & A 2008;5():2-2.</p><p>Published online 20 Feb 2008</p><p>PMCID:PMC2291031.</p><p></p